Related Experiment Videos
Hyponatraemia in acute brain disease.
M Kröll1, M Juhler, J Lindholm
1Department of Neurosurgery, Rigshospitalet, University Hospital, Copenhagen, Denmark.
Journal of Internal Medicine
|October 1, 1992
Summary
Hyponatraemia, a low sodium level, can stem from various causes like cerebral salt wasting or SIADH. Rapid correction with furosemide and saline effectively treats symptomatic hyponatraemia.
Area of Science:
- Nephrology
- Neurology
- Endocrinology
Background:
- Hyponatraemia (HN) presents diverse etiologies requiring individualized treatment.
- Two primary theories for HN in acute brain disease include cerebral salt wasting syndrome (CSWS) and syndrome of inappropriate antidiuretic hormone secretion (SIADH).
- A third proposed mechanism is 'sodium shift' between intracellular and extracellular spaces.
Purpose of the Study:
- To review the mechanisms of hyponatraemia in acute brain disease.
- To discuss the clinical significance of the rate of hyponatraemia development.
- To outline therapeutic strategies for symptomatic hyponatraemia.
Main Methods:
- Literature review of hyponatraemia mechanisms.
- Analysis of factors contributing to morbidity and mortality in hyponatraemia.
- Discussion of treatment outcomes for rapid hyponatraemia correction.
Main Results:
- Morbidity and mortality in HN are associated with rapid development (≥ 0.5 mmol/h).
- Cerebral salt wasting syndrome (CSWS) involves excessive natriuresis.
- Syndrome of inappropriate antidiuretic hormone secretion (SIADH) leads to water retention.
Conclusions:
- Hyponatraemia management must be tailored to the underlying cause.
- Rapid correction of symptomatic hyponatraemia using furosemide and 3% sodium chloride is effective.
- Understanding the rate of HN development is crucial for assessing risk and guiding therapy.